Strumento inattivo

Altre lingue Xenetic Biosciences Inc Nasdaq

Azioni

US9840152063

Altre lingue

Sblocca tutte le notizie: sii il primo a essere informato e reagisci prima dei mercati!

Xenetic Biosciences : Announces Executive Leadership Transition - Form 8-K	22/05
Xenetic Biosciences, Inc. Announces Management Resignations	22/05
Xenetic Biosciences, Inc. Announces Chief Executive Officer Changes	22/05
Xenetic Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update	13/05
Xenetic Biosciences : Reports First Quarter 2024 Financial Results and Provides Business Update - Form 8-K	10/05
Xenetic Biosciences: Q1 Earnings Snapshot	10/05
Xenetic Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
Xenetic Biosciences, Inc. Reports Full Year 2023 Financial Results	25/03
Xenetic Biosciences : Reports Full Year 2023 Financial Results - Form 8-K	22/03
Xenetic Biosciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21/03
CLS Therapeutics Discloses its Views on Xenetic Biosciences	18/03
Xenetic Biosciences, Inc. Enters into Research Agreement with the University of Virginia for the Advancement of Its DNase-Based Oncology Platform	17/01
Xenetic Biosciences: Q3 Earnings Snapshot	10/11
Xenetic Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11
Xenetic Biosciences, Inc. to Participate at the Virtual Investor Ask the CEO Conference	12/10/23
Xenetic Biosciences: Q2 Earnings Snapshot	11/08/23
Xenetic Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
North American Morning Briefing : Debt-Ceiling -2-	17/05/23
Xenetic Biosciences to Implement 1-for-10 Reverse Split	12/05/23
Xenetic Biosciences: Q1 Earnings Snapshot	11/05/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Xenetic Biosciences Inc Nasdaq

Azioni

US9840152063

Altre lingue

Filtri